Earlier quoted context omitted.
As opposed to more standard research funding which isn't as goal oriented. I assume they're looking for a "billion dollar exit" from their research funding.
Overemphasis on commercialization is a common complaint of the current funding situation in medical research, so I don't think we're failing for lack of interest in commercial exits. In fact, many scientist are serial entrepreneurs. Moreover, many discoveries that went on to make a lot of people a lot of money had no obvious commercial application when they were first being researched... Predicting future markets is…
I mean "achieves their targets by reducing the total burden of disease on humanity", which is a different radical exit.